Therapeutic ratio of mono or combination bacterial lipopolysaccharide therapy in methylnitrosourea — induced rat mammary carcinoma View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1987-08

AUTHORS

M. R. Berger, E. Petru, D. Schmähl

ABSTRACT

Four experiments investigating the antitumor activity of bacterial lipopolysaccharide (LPS) against the autochthonous methylnitrosourea — induced mammary carcinoma are summarized. Administration of LPS alone i.v. caused distinct regression of small tumors following its first injection. This therapeutic effect, however, was short-lived and could not be maintained by administering a second dose. The observed antineoplastic activity of LPS was dose-related, whereas no dose-response relationship was observed with respect to its toxicity. A series of experiments in which LPS was combined with other compounds to possibly exploit its activity while reducing the toxicity were performed. Neither the combination with cytotoxic drugs such as 4′-(9-acridinylamino.)-methansulfone-m-aniside or cyclophosphamide nor that will 1-octadecyl-2-methoxy-rac-glycero-3-phosphocholine or hexadecylphosphocholine showed sufficient anticancer activity at acceptable toxicity. In all experiments promising efficacy was observed at high dosages but also high toxicity. When the dosages were reduced, diminished antineoplastic activity was found together with overproportionally high mortality. It might therefore be concluded that the active dose range of LPS cannot be reached clinically because of its inherent toxicity. More... »

PAGES

437-445

References to SciGraph publications

  • 1984-03. Immunostimulation in JOURNAL OF MOLECULAR MEDICINE
  • 1984-07. Evaluation of new estrogen-linked 2-chloroethylnitrosoureas in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 1966-12. Chemotherapie-Versuche mit Endoxan an autochthonen Benzpyren-Sarkomen bei Ratten und Mäusen in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 1985. Grundlagen der Immunologie maligner Tumoren in INTERNISTISCHE KREBSTHERAPIE
  • 1984-11. Phase-I study of intravenous modified lipid A in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 1986-02-01. Hexadecylphosphocholine, a new Antineoplastic Agent: Cytotoxic properties in leukaemic cells in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 1986-02-01. Alkylphosphocholines as Anticancer Agents in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/bf00390037

    DOI

    http://dx.doi.org/10.1007/bf00390037

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1044441105

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/3624299


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Pharmacology and Pharmaceutical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Combined Modality Therapy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Dose-Response Relationship, Immunologic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lipopolysaccharides", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mammary Neoplasms, Experimental", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Methylnitrosourea", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Rats", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Rats, Inbred Strains", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, D-6900, Heidelberg, Federal Republic of Germany", 
              "id": "http://www.grid.ac/institutes/grid.7497.d", 
              "name": [
                "Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, D-6900, Heidelberg, Federal Republic of Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Berger", 
            "givenName": "M. R.", 
            "id": "sg:person.01256203524.22", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256203524.22"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, D-6900, Heidelberg, Federal Republic of Germany", 
              "id": "http://www.grid.ac/institutes/grid.7497.d", 
              "name": [
                "Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, D-6900, Heidelberg, Federal Republic of Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Petru", 
            "givenName": "E.", 
            "id": "sg:person.01063471533.53", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01063471533.53"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, D-6900, Heidelberg, Federal Republic of Germany", 
              "id": "http://www.grid.ac/institutes/grid.7497.d", 
              "name": [
                "Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, D-6900, Heidelberg, Federal Republic of Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Schm\u00e4hl", 
            "givenName": "D.", 
            "id": "sg:person.0105462430.55", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0105462430.55"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/bf02579866", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018583668", 
              "https://doi.org/10.1007/bf02579866"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf01721886", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032980686", 
              "https://doi.org/10.1007/bf01721886"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00205743", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004846907", 
              "https://doi.org/10.1007/bf00205743"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00390987", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046095875", 
              "https://doi.org/10.1007/bf00390987"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00524423", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024213231", 
              "https://doi.org/10.1007/bf00524423"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-3-642-69712-8_7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024542557", 
              "https://doi.org/10.1007/978-3-642-69712-8_7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf02579867", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001638973", 
              "https://doi.org/10.1007/bf02579867"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1987-08", 
        "datePublishedReg": "1987-08-01", 
        "description": "Four experiments investigating the antitumor activity of bacterial lipopolysaccharide (LPS) against the autochthonous methylnitrosourea \u2014 induced mammary carcinoma are summarized. Administration of LPS alone i.v. caused distinct regression of small tumors following its first injection. This therapeutic effect, however, was short-lived and could not be maintained by administering a second dose. The observed antineoplastic activity of LPS was dose-related, whereas no dose-response relationship was observed with respect to its toxicity. A series of experiments in which LPS was combined with other compounds to possibly exploit its activity while reducing the toxicity were performed. Neither the combination with cytotoxic drugs such as 4\u2032-(9-acridinylamino.)-methansulfone-m-aniside or cyclophosphamide nor that will 1-octadecyl-2-methoxy-rac-glycero-3-phosphocholine or hexadecylphosphocholine showed sufficient anticancer activity at acceptable toxicity. In all experiments promising efficacy was observed at high dosages but also high toxicity. When the dosages were reduced, diminished antineoplastic activity was found together with overproportionally high mortality. It might therefore be concluded that the active dose range of LPS cannot be reached clinically because of its inherent toxicity.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/bf00390037", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1313647", 
            "issn": [
              "0171-5216", 
              "1432-1335"
            ], 
            "name": "Journal of Cancer Research and Clinical Oncology", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "5", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "113"
          }
        ], 
        "keywords": [
          "mammary carcinoma", 
          "methylnitrosourea-induced mammary carcinoma", 
          "antineoplastic activity", 
          "administration of lipopolysaccharide", 
          "active dose range", 
          "rat mammary carcinomas", 
          "dose-response relationship", 
          "acceptable toxicity", 
          "second dose", 
          "promising efficacy", 
          "small tumors", 
          "first injection", 
          "therapeutic effect", 
          "therapeutic ratio", 
          "cytotoxic drugs", 
          "high mortality", 
          "bacterial lipopolysaccharide", 
          "lipopolysaccharide", 
          "antitumor activity", 
          "dose range", 
          "high dosage", 
          "carcinoma", 
          "toxicity", 
          "anticancer activity", 
          "dosage", 
          "cyclophosphamide", 
          "inherent toxicity", 
          "therapy", 
          "activity", 
          "tumors", 
          "mortality", 
          "distinct regression", 
          "administration", 
          "dose", 
          "drugs", 
          "methylnitrosourea", 
          "efficacy", 
          "injection", 
          "high toxicity", 
          "hexadecylphosphocholine", 
          "regression", 
          "aniside", 
          "effect", 
          "combination", 
          "series of experiments", 
          "relationship", 
          "ratio", 
          "series", 
          "compounds", 
          "respect", 
          "experiments", 
          "mono", 
          "range"
        ], 
        "name": "Therapeutic ratio of mono or combination bacterial lipopolysaccharide therapy in methylnitrosourea \u2014 induced rat mammary carcinoma", 
        "pagination": "437-445", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1044441105"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/bf00390037"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "3624299"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/bf00390037", 
          "https://app.dimensions.ai/details/publication/pub.1044441105"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-12-01T06:19", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_186.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/bf00390037"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00390037'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00390037'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00390037'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00390037'


     

    This table displays all metadata directly associated to this object as RDF triples.

    196 TRIPLES      21 PREDICATES      96 URIs      81 LITERALS      17 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/bf00390037 schema:about N4a8b04b4c3a048f793e52759bff2a583
    2 N5a1f5e238a934582889c499e7c0cadb3
    3 N5ce52b2add424d85bafeaf678072c49a
    4 N8728edbcb93041ef9e333f3cbf18771b
    5 N9b38c875c00d41ad9cd71a1e85d07a4c
    6 Na4cd3b0f97664017b96943d9f340f572
    7 Nb45e062874614673ade2769b252f9691
    8 Ne69735b3c4c349949bd393b8b8067142
    9 Nf06f7f0cd6724682a363ce1839da3cdb
    10 Nf6e53f105aa048dcb689734e99492995
    11 anzsrc-for:11
    12 anzsrc-for:1115
    13 schema:author N59c5599b451f42da84e22e54d27b5995
    14 schema:citation sg:pub.10.1007/978-3-642-69712-8_7
    15 sg:pub.10.1007/bf00205743
    16 sg:pub.10.1007/bf00390987
    17 sg:pub.10.1007/bf00524423
    18 sg:pub.10.1007/bf01721886
    19 sg:pub.10.1007/bf02579866
    20 sg:pub.10.1007/bf02579867
    21 schema:datePublished 1987-08
    22 schema:datePublishedReg 1987-08-01
    23 schema:description Four experiments investigating the antitumor activity of bacterial lipopolysaccharide (LPS) against the autochthonous methylnitrosourea — induced mammary carcinoma are summarized. Administration of LPS alone i.v. caused distinct regression of small tumors following its first injection. This therapeutic effect, however, was short-lived and could not be maintained by administering a second dose. The observed antineoplastic activity of LPS was dose-related, whereas no dose-response relationship was observed with respect to its toxicity. A series of experiments in which LPS was combined with other compounds to possibly exploit its activity while reducing the toxicity were performed. Neither the combination with cytotoxic drugs such as 4′-(9-acridinylamino.)-methansulfone-m-aniside or cyclophosphamide nor that will 1-octadecyl-2-methoxy-rac-glycero-3-phosphocholine or hexadecylphosphocholine showed sufficient anticancer activity at acceptable toxicity. In all experiments promising efficacy was observed at high dosages but also high toxicity. When the dosages were reduced, diminished antineoplastic activity was found together with overproportionally high mortality. It might therefore be concluded that the active dose range of LPS cannot be reached clinically because of its inherent toxicity.
    24 schema:genre article
    25 schema:isAccessibleForFree false
    26 schema:isPartOf N56a0f45a4c15474e82502cdeb31220f6
    27 Na8634c90ef3a4def9ed520037a261073
    28 sg:journal.1313647
    29 schema:keywords acceptable toxicity
    30 active dose range
    31 activity
    32 administration
    33 administration of lipopolysaccharide
    34 aniside
    35 anticancer activity
    36 antineoplastic activity
    37 antitumor activity
    38 bacterial lipopolysaccharide
    39 carcinoma
    40 combination
    41 compounds
    42 cyclophosphamide
    43 cytotoxic drugs
    44 distinct regression
    45 dosage
    46 dose
    47 dose range
    48 dose-response relationship
    49 drugs
    50 effect
    51 efficacy
    52 experiments
    53 first injection
    54 hexadecylphosphocholine
    55 high dosage
    56 high mortality
    57 high toxicity
    58 inherent toxicity
    59 injection
    60 lipopolysaccharide
    61 mammary carcinoma
    62 methylnitrosourea
    63 methylnitrosourea-induced mammary carcinoma
    64 mono
    65 mortality
    66 promising efficacy
    67 range
    68 rat mammary carcinomas
    69 ratio
    70 regression
    71 relationship
    72 respect
    73 second dose
    74 series
    75 series of experiments
    76 small tumors
    77 therapeutic effect
    78 therapeutic ratio
    79 therapy
    80 toxicity
    81 tumors
    82 schema:name Therapeutic ratio of mono or combination bacterial lipopolysaccharide therapy in methylnitrosourea — induced rat mammary carcinoma
    83 schema:pagination 437-445
    84 schema:productId N6465afac76544d74b3df1265ebfeb55c
    85 N9615e412b94d404c88add05e5cdef701
    86 N9b774be808a44b6980f885e4e14d3862
    87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044441105
    88 https://doi.org/10.1007/bf00390037
    89 schema:sdDatePublished 2022-12-01T06:19
    90 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    91 schema:sdPublisher N29eafc94b9ee4929b042ddb8ab63eee7
    92 schema:url https://doi.org/10.1007/bf00390037
    93 sgo:license sg:explorer/license/
    94 sgo:sdDataset articles
    95 rdf:type schema:ScholarlyArticle
    96 N29eafc94b9ee4929b042ddb8ab63eee7 schema:name Springer Nature - SN SciGraph project
    97 rdf:type schema:Organization
    98 N4a8b04b4c3a048f793e52759bff2a583 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    99 schema:name Dose-Response Relationship, Immunologic
    100 rdf:type schema:DefinedTerm
    101 N556c4b2c3d3249638d5049bd139632cd rdf:first sg:person.01063471533.53
    102 rdf:rest Nec09441c31b544778d172848b2f807c9
    103 N56a0f45a4c15474e82502cdeb31220f6 schema:volumeNumber 113
    104 rdf:type schema:PublicationVolume
    105 N59c5599b451f42da84e22e54d27b5995 rdf:first sg:person.01256203524.22
    106 rdf:rest N556c4b2c3d3249638d5049bd139632cd
    107 N5a1f5e238a934582889c499e7c0cadb3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    108 schema:name Lipopolysaccharides
    109 rdf:type schema:DefinedTerm
    110 N5ce52b2add424d85bafeaf678072c49a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    111 schema:name Combined Modality Therapy
    112 rdf:type schema:DefinedTerm
    113 N6465afac76544d74b3df1265ebfeb55c schema:name dimensions_id
    114 schema:value pub.1044441105
    115 rdf:type schema:PropertyValue
    116 N8728edbcb93041ef9e333f3cbf18771b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    117 schema:name Rats, Inbred Strains
    118 rdf:type schema:DefinedTerm
    119 N9615e412b94d404c88add05e5cdef701 schema:name pubmed_id
    120 schema:value 3624299
    121 rdf:type schema:PropertyValue
    122 N9b38c875c00d41ad9cd71a1e85d07a4c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    123 schema:name Mammary Neoplasms, Experimental
    124 rdf:type schema:DefinedTerm
    125 N9b774be808a44b6980f885e4e14d3862 schema:name doi
    126 schema:value 10.1007/bf00390037
    127 rdf:type schema:PropertyValue
    128 Na4cd3b0f97664017b96943d9f340f572 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    129 schema:name Methylnitrosourea
    130 rdf:type schema:DefinedTerm
    131 Na8634c90ef3a4def9ed520037a261073 schema:issueNumber 5
    132 rdf:type schema:PublicationIssue
    133 Nb45e062874614673ade2769b252f9691 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    134 schema:name Female
    135 rdf:type schema:DefinedTerm
    136 Ne69735b3c4c349949bd393b8b8067142 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    137 schema:name Antineoplastic Agents
    138 rdf:type schema:DefinedTerm
    139 Nec09441c31b544778d172848b2f807c9 rdf:first sg:person.0105462430.55
    140 rdf:rest rdf:nil
    141 Nf06f7f0cd6724682a363ce1839da3cdb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Rats
    143 rdf:type schema:DefinedTerm
    144 Nf6e53f105aa048dcb689734e99492995 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    145 schema:name Animals
    146 rdf:type schema:DefinedTerm
    147 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    148 schema:name Medical and Health Sciences
    149 rdf:type schema:DefinedTerm
    150 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
    151 schema:name Pharmacology and Pharmaceutical Sciences
    152 rdf:type schema:DefinedTerm
    153 sg:journal.1313647 schema:issn 0171-5216
    154 1432-1335
    155 schema:name Journal of Cancer Research and Clinical Oncology
    156 schema:publisher Springer Nature
    157 rdf:type schema:Periodical
    158 sg:person.0105462430.55 schema:affiliation grid-institutes:grid.7497.d
    159 schema:familyName Schmähl
    160 schema:givenName D.
    161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0105462430.55
    162 rdf:type schema:Person
    163 sg:person.01063471533.53 schema:affiliation grid-institutes:grid.7497.d
    164 schema:familyName Petru
    165 schema:givenName E.
    166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01063471533.53
    167 rdf:type schema:Person
    168 sg:person.01256203524.22 schema:affiliation grid-institutes:grid.7497.d
    169 schema:familyName Berger
    170 schema:givenName M. R.
    171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256203524.22
    172 rdf:type schema:Person
    173 sg:pub.10.1007/978-3-642-69712-8_7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024542557
    174 https://doi.org/10.1007/978-3-642-69712-8_7
    175 rdf:type schema:CreativeWork
    176 sg:pub.10.1007/bf00205743 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004846907
    177 https://doi.org/10.1007/bf00205743
    178 rdf:type schema:CreativeWork
    179 sg:pub.10.1007/bf00390987 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046095875
    180 https://doi.org/10.1007/bf00390987
    181 rdf:type schema:CreativeWork
    182 sg:pub.10.1007/bf00524423 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024213231
    183 https://doi.org/10.1007/bf00524423
    184 rdf:type schema:CreativeWork
    185 sg:pub.10.1007/bf01721886 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032980686
    186 https://doi.org/10.1007/bf01721886
    187 rdf:type schema:CreativeWork
    188 sg:pub.10.1007/bf02579866 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018583668
    189 https://doi.org/10.1007/bf02579866
    190 rdf:type schema:CreativeWork
    191 sg:pub.10.1007/bf02579867 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001638973
    192 https://doi.org/10.1007/bf02579867
    193 rdf:type schema:CreativeWork
    194 grid-institutes:grid.7497.d schema:alternateName Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, D-6900, Heidelberg, Federal Republic of Germany
    195 schema:name Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, D-6900, Heidelberg, Federal Republic of Germany
    196 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...